Results 161 to 170 of about 3,268,362 (310)

Irish Human Rights Commission submission to the UN Human Rights Committee on the examination of Ireland's fourth periodic report under the international covenant on civil and political rights

open access: yes, 2004
The Irish Human Rights Commission (IHRC) is Ireland’s National Human Rights Institution (NHRI), set up by the Irish Government under the Human Rights Commission Acts 2000 and 2001.1 The IHRC has a statutory remit under the Human Rights Commission Act ...
Irish Human Rights Commission (IHRC)
core  

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

open access: yesMolecular Oncology, EarlyView.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu   +3 more
wiley   +1 more source

Public Health Policy Responses to Population Aging in Mexico: A Rights-Based and Socio-Legal Approach. [PDF]

open access: yesHealthcare (Basel)
Rojas P   +5 more
europepmc   +1 more source

Sexual Harassment is Discrimination

open access: yes, 2010
Sexual Harassment is Sex Discrimination -- Recognizing Sexual Harassment -- Categories of Sexual Harassment -- The Six Components of Sexual Harassment -- Types of Behaviors Which May be Labeled as Sexual Harassment -- First Type of Sexual Harassment ...
Kansas Human Rights Commission.
core  

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Ohio Legal Rights Service quarterly

open access: yes, 2002
Began with Issue 1, v. 1 (Summer 2002); - Vol. 5, issue 5 (Nov. 2007); Winter 2008-; "The News from Ohio Legal Rights Service, Ohio's Protection & Advocacy System for People with Disabilities."; Description based on: Vol. 5, issue 5 (Nov.
Ohio Legal Rights Service.
core  

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy